Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleLetter: loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease—authors' reply.AuthorsMahmoud, Remi; Schultheiss, Johannes P. D.; Fidder, Herma H.; Oldenburg, BasAbstractLINKED CONTENT: This article is linked to Schultheiss et al papers. To view these articles, visit https://doi.org/10.1111/apt.16605 and https://doi.org/10.1111/apt.16713SubjectsINFLAMMATORY bowel diseases; TREATMENT durationPublicationAlimentary Pharmacology & Therapeutics, 2022, Vol 55, Issue 4, p499ISSN0269-2813Publication typeArticleDOI10.1111/apt.16757